• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

逐步酸化的有机/无机杂化药物输送系统用于癌症治疗。

Stepwise-acid-active organic/inorganic hybrid drug delivery system for cancer therapy.

机构信息

Hubei Collaborative Innovation Center for Advanced Organic Chemical Materials, Key Laboratory for the Green Preparation and Application of Functional Materials of Ministry of Education, Hubei University, Wuhan, Hubei 430062, PR China.

Glyn O. Philips Hydrocolloid Research Centre at HUT, Hubei University of Technology, Wuhan, Hubei 430068, PR China.

出版信息

Colloids Surf B Biointerfaces. 2018 Jul 1;167:407-414. doi: 10.1016/j.colsurfb.2018.04.038. Epub 2018 Apr 21.

DOI:10.1016/j.colsurfb.2018.04.038
PMID:29704741
Abstract

Due to the difference of pH values between normal tissues, tumor tissues and intracellular environments, DOX@MSN-CD-PEG, a stepwise-acid-active organic/inorganic hybrid drug delivery system (DDS) was reported in this article. The inorganic mesoporous silica nanoparticle (MSN) was introduced for loading of doxorubicin hydrochloride (DOX). Then organic components were applied to achieve the stepwise-acid-active intracellular drug release: MSN was capped with a β-cyclodextrine (β-CD) based host-guest system via pH-sensitive epoxy bond. Then PEG was grafted outside of the carriers through pH-sensitive benzoic imine bond. With the protection of PEG layer, the carriers were difficult cellular uptake by normal cells but could be "acid-activated" for cytophagy by cancer cells in the slightly acidic environments in tumor tissues because of the abscission of PEG. Inside the cells, the more acidic environments could further "activate" the carriers to release DOX as the leaving of the host-guest system. The fabrication processes of DOX@MSN-CD-PEG were monitored. And the stepwise-acid-active property of which was investigated by acid-triggered PEG abscission studies and in vitro drug release studies at pH 7.4 and 6.5, respectively. The in vitro cellular cytotoxicity and cellular uptake behavior were also investigated. In summary, the stepwise-acid-active hybrid DDS should be considerable for cancer therapy.

摘要

由于正常组织、肿瘤组织和细胞内环境之间 pH 值的差异,本文报道了一种逐步酸激活的有机/无机杂化药物传递系统(DDS)DOX@MSN-CD-PEG。引入了无机介孔硅纳米颗粒(MSN)来负载盐酸多柔比星(DOX)。然后应用有机成分实现逐步酸激活的细胞内药物释放:MSN 通过 pH 敏感的环氧键与基于β-环糊精(β-CD)的主客体系统封闭。然后通过 pH 敏感的苯甲酰亚胺键将 PEG 接枝在载体的外部。由于 PEG 层的保护,载体很难被正常细胞摄取,但可以在肿瘤组织中稍酸性环境中的癌细胞中被“酸激活”进行细胞吞噬,因为 PEG 的脱落。在细胞内,更酸性的环境可以进一步“激活”载体以释放 DOX,因为主客体系统的离去。监测了 DOX@MSN-CD-PEG 的制备过程。通过酸触发 PEG 脱落研究和分别在 pH 值为 7.4 和 6.5 时的体外药物释放研究,研究了其逐步酸激活特性。还研究了体外细胞毒性和细胞摄取行为。总之,这种逐步酸激活的杂化 DDS 应该对癌症治疗有很大的意义。

相似文献

1
Stepwise-acid-active organic/inorganic hybrid drug delivery system for cancer therapy.逐步酸化的有机/无机杂化药物输送系统用于癌症治疗。
Colloids Surf B Biointerfaces. 2018 Jul 1;167:407-414. doi: 10.1016/j.colsurfb.2018.04.038. Epub 2018 Apr 21.
2
A chitosan/mesoporous silica nanoparticle-based anticancer drug delivery system with a "tumor-triggered targeting" property.基于壳聚糖/介孔硅纳米粒子的具有“肿瘤触发靶向”特性的抗癌药物输送系统。
Int J Biol Macromol. 2021 Jul 31;183:2017-2029. doi: 10.1016/j.ijbiomac.2021.06.004. Epub 2021 Jun 7.
3
Poly(amino acid)/ZnO/mesoporous silica nanoparticle based complex drug delivery system with a charge-reversal property for cancer therapy.基于聚(氨基酸)/氧化锌/介孔硅纳米粒子的具有荷反转性质的复杂药物输送系统,用于癌症治疗。
Colloids Surf B Biointerfaces. 2019 Sep 1;181:461-469. doi: 10.1016/j.colsurfb.2019.05.078. Epub 2019 May 31.
4
A dual-functional HER2 aptamer-conjugated, pH-activated mesoporous silica nanocarrier-based drug delivery system provides in vitro synergistic cytotoxicity in HER2-positive breast cancer cells.一种双功能 HER2 适体偶联、pH 激活的介孔硅纳米载体药物传递系统,为 HER2 阳性乳腺癌细胞提供体外协同细胞毒性。
Int J Nanomedicine. 2019 May 31;14:4029-4044. doi: 10.2147/IJN.S201688. eCollection 2019.
5
Thermo-responsive mesoporous silica/lipid bilayer hybrid nanoparticles for doxorubicin on-demand delivery and reduced premature release.温敏介孔硅/脂质双层杂化纳米粒用于阿霉素按需释放和减少早期释放。
Colloids Surf B Biointerfaces. 2017 Dec 1;160:527-534. doi: 10.1016/j.colsurfb.2017.10.005. Epub 2017 Oct 5.
6
A dual-sensitive mesoporous silica nanoparticle based drug carrier for cancer synergetic therapy.一种基于双敏感介孔硅纳米粒子的药物载体用于癌症协同治疗。
Colloids Surf B Biointerfaces. 2019 Mar 1;175:65-72. doi: 10.1016/j.colsurfb.2018.11.071. Epub 2018 Nov 28.
7
Contribution of carboxyl modified chiral mesoporous silica nanoparticles in delivering doxorubicin hydrochloride in vitro: pH-response controlled release, enhanced drug cellular uptake and cytotoxicity.羧基修饰的手性介孔二氧化硅纳米粒子在体外递送盐酸阿霉素中的作用:pH响应控释、增强药物细胞摄取及细胞毒性
Colloids Surf B Biointerfaces. 2016 May 1;141:374-381. doi: 10.1016/j.colsurfb.2016.02.009. Epub 2016 Feb 6.
8
Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.用于细胞内酸触发药物递送的天然明胶封端介孔硅纳米粒子。
Langmuir. 2013 Oct 15;29(41):12804-10. doi: 10.1021/la4022646. Epub 2013 Oct 3.
9
A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery.一种用于阿霉素在聚乙二醇化介孔二氧化硅纳米颗粒表面配位结合的表面接枝配体功能化策略:迈向pH响应型药物递送
Colloids Surf B Biointerfaces. 2017 Jan 1;149:138-145. doi: 10.1016/j.colsurfb.2016.10.018. Epub 2016 Oct 11.
10
pH-sensitive poly(glutamic acid) grafted mesoporous silica nanoparticles for drug delivery.pH 敏感的聚谷氨酸接枝介孔硅纳米粒子用于药物递送。
Int J Pharm. 2013 Jun 25;450(1-2):296-303. doi: 10.1016/j.ijpharm.2013.04.014. Epub 2013 Apr 15.

引用本文的文献

1
Current status of controlled onco-therapies based on metal organic frameworks.基于金属有机框架的可控肿瘤治疗的现状
RSC Adv. 2024 Apr 19;14(18):12817-12828. doi: 10.1039/d4ra00375f. eCollection 2024 Apr 16.
2
Drug Delivery Systems with a "Tumor-Triggered" Targeting or Intracellular Drug Release Property Based on DePEGylation.基于去聚乙二醇化的具有“肿瘤触发”靶向或细胞内药物释放特性的药物递送系统。
Materials (Basel). 2022 Jul 31;15(15):5290. doi: 10.3390/ma15155290.
3
The combination of MnO@Lipo-coated gefitinib and bevacizumab inhibits the development of non-small cell lung cancer.
MnO@Lipo 包裹吉非替尼与贝伐珠单抗联合抑制非小细胞肺癌的发展。
Drug Deliv. 2022 Dec;29(1):466-477. doi: 10.1080/10717544.2022.2032872.
4
pH-Sensitive Biomaterials for Drug Delivery.pH 敏感型药物递送生物材料
Molecules. 2020 Nov 30;25(23):5649. doi: 10.3390/molecules25235649.